Intranasal insulin therapy for cognitive impairment and neurodegeneration: current state of the art
about
Obesity Reduces Cognitive and Motor Functions across the LifespanThe effect of insulin and insulin-like growth factors on hippocampus- and amygdala-dependent long-term memory formationBrain Uptake of Neurotherapeutics after Intranasal versus Intraperitoneal Delivery in Mice.Brain signaling systems in the Type 2 diabetes and metabolic syndrome: promising target to treat and prevent these diseases.Neuron-specific regulation of class I PI3K catalytic subunits and their dysfunction in brain disorders.Knowledge-Based Compact Disease Models: A Rapid Path from High-Throughput Data to Understanding Causative Mechanisms for a Complex Disease.Insulin Resistance and Neurodegeneration: Progress Towards the Development of New Therapeutics for Alzheimer's Disease.Impact of Single or Repeated Dose Intranasal Zinc-free Insulin in Young and Aged F344 Rats on Cognition, Signaling, and Brain Metabolism.Short-lived diabetes in the young-adult ZDF rat does not exacerbate neuronal Ca(2+) biomarkers of aging.Brain Insulin Administration Triggers Distinct Cognitive and Neurotrophic Responses in Young and Aged Rats.Brain catalase in the streptozotocin-rat model of sporadic Alzheimer's disease treated with the iron chelator-monoamine oxidase inhibitor, M30.Intranasal delivery of N-terminal modified leptin-pluronic conjugate for treatment of obesity.Novel calcium-related targets of insulin in hippocampal neurons.Garlic extract attenuates brain mitochondrial dysfunction and cognitive deficit in obese-insulin resistant rats.Streptozotocin-induced β-cell damage, high fat diet, and metformin administration regulate Hes3 expression in the adult mouse brainPossible Clues for Brain Energy Translation via Endolysosomal Trafficking of APP-CTFs in Alzheimer's Disease
P2860
Q26765753-DF929EBA-61B5-4404-8B61-2171ECC8157EQ34245876-8204910A-28B5-407C-AEA5-3F7A292F49D3Q36052412-BD64A014-90BC-452F-A9DE-857B6263CD2DQ37474214-68062BFA-77BB-4888-940A-228155BE693DQ38193084-56E40E06-DDC0-4538-8B23-71918EB287F7Q38371546-663963F9-DD2C-4ECC-B8EA-0FFF1389D65EQ39042377-5BF6F96E-C8D4-4B40-A08A-B19D24596637Q39858501-C6390760-6547-46B4-957E-373C54404B1EQ40373443-795E2F6C-38C3-4DFC-A8A4-02A9B3D4AFFAQ40397738-9A1232EC-10B7-41CD-BA7A-CDB888EF8736Q46834377-C15C51C5-9360-4218-A690-2DBFDAA1438CQ47933830-27B8DC5E-516E-47F3-905B-2BB8B22637AEQ48100959-DCCC4837-27A6-4678-8757-777E9CE4E5E4Q48473278-40D365B4-EEA8-4A07-BD83-2852C674A389Q57314980-68D29B52-2E01-4D01-8146-B3DA85A1DCA6Q58695146-43DF5077-0DDF-4DAA-BCA8-3F1E6E49D799
P2860
Intranasal insulin therapy for cognitive impairment and neurodegeneration: current state of the art
description
2013 nî lūn-bûn
@nan
2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Intranasal insulin therapy for ...... tion: current state of the art
@ast
Intranasal insulin therapy for ...... tion: current state of the art
@en
Intranasal insulin therapy for ...... tion: current state of the art
@nl
type
label
Intranasal insulin therapy for ...... tion: current state of the art
@ast
Intranasal insulin therapy for ...... tion: current state of the art
@en
Intranasal insulin therapy for ...... tion: current state of the art
@nl
prefLabel
Intranasal insulin therapy for ...... tion: current state of the art
@ast
Intranasal insulin therapy for ...... tion: current state of the art
@en
Intranasal insulin therapy for ...... tion: current state of the art
@nl
P2860
P1476
Intranasal insulin therapy for ...... tion: current state of the art
@en
P2093
Suzanne M de la Monte
P2860
P304
P356
10.1517/17425247.2013.856877
P407
P577
2013-12-01T00:00:00Z